| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |